Expanding the Impact of SGLT2 Inhibitors in Chronic Kidney Disease.

Makawi, Alaa T; Tawfik, Yahya M K; Dixon, Dave L; McMahon, Gearoid M; Buckley, Leo F

Makawi, Alaa T; Tawfik, Yahya M K; Dixon, Dave L; McMahon, Gearoid M; Buckley, Leo F.

Afiliación

Makawi AT; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Tawfik YMK; Department of Pharmacy Practice, College of Pharmacy, Umm Al Qura University, Makkah, Saudi Arabia.
Dixon DL; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
McMahon GM; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Buckley LF; Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University, Richmond, Virginia, USA.

Am J Nephrol ; : 1-4, 2024 Feb 28.

Article en En | MEDLINE | ID: mdl-38417403

Palabras clave

Implementation; Population health; SGLT2 inhibitors

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Am J Nephrol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google